Gene · 4100
Papers1,534
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 1,534
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Landscape of helper and regulatory antitumour CD4+ T cells in melanoma. | Nature | 2022 | 35508657 | PubTator, text mining | PubMed |
| Perspectives for Combining Viral Oncolysis With Additional Immunotherapies for the Treatment of Melanoma. | Front Mol Biosci | 2022 | 35495634 | PubTator, text mining | PubMed |
| Therapeutic Vaccines Targeting Neoantigens to Induce T-Cell Immunity against Cancers. | Pharmaceutics | 2022 | 35456701 | PubTator, text mining | PubMed |
| CAR-T Cells for the Treatment of Lung Cancer. | Life (Basel) | 2022 | 35455052 | PubTator, text mining | PubMed |
| Epoxiconazole alters the histology and transcriptome of mouse liver in a transgenerational pattern. | Chem Biol Interact | 2022 | 35436446 | PubTator, text mining | PubMed |
| Novel Immunotherapies for Osteosarcoma. | Front Oncol | 2022 | 35433427 | PubTator, text mining | PubMed |
| Neoantigen-specific CD4+ T cells in human melanoma have diverse differentiation states and correlate with CD8+ T cell, macrophage, and B cell function. | Cancer Cell | 2022 | 35413271 | PubTator, text mining | PubMed |
| Isolation of Neoantigen-Specific Human T Cell Receptors from Different Human and Murine Repertoires. | Cancers (Basel) | 2022 | 35406613 | PubTator, text mining | PubMed |
| Anti-cancer peptide-based therapeutic strategies in solid tumors. | Cell Mol Biol Lett | 2022 | 35397496 | PubTator, text mining | PubMed |
| Antibodies as biomarkers for cancer risk: a systematic review. | Clin Exp Immunol | 2022 | 35380164 | PubTator, text mining | PubMed |
| Chimeric antigen receptor T-cell therapy: challenges and opportunities in lung cancer. | Antib Ther | 2022 | 35372786 | PubTator, text mining | PubMed |
| Camrelizumab Combined With Gemcitabine and Albumin-Bound Paclitaxel for Neoadjuvant Therapy in the Treatment of Progressive Gallbladder Cancer: A Case Report. | Front Oncol | 2022 | 35372051 | PubTator, text mining | PubMed |
| mRNA cancer vaccines: Advances, trends and challenges. | Acta Pharm Sin B | 2022 | 35345451 | PubTator, text mining | PubMed |
| Immunotherapy of glioblastoma: Recent advances and future prospects. | Hum Vaccin Immunother | 2022 | 35344682 | PubTator, text mining | PubMed |
| Advanced Biomaterials for Cell-Specific Modulation and Restore of Cancer Immunotherapy. | Adv Sci (Weinh) | 2022 | 35343112 | PubTator, text mining | PubMed |
| Development of Peptide-Based Vaccines for Cancer. | J Oncol | 2022 | 35342400 | PubTator, text mining | PubMed |
| Nonviral Delivery Systems of mRNA Vaccines for Cancer Gene Therapy. | Pharmaceutics | 2022 | 35335891 | PubTator, text mining | PubMed |
| The Interplay between Tumour Microenvironment Components in Malignant Melanoma. | Medicina (Kaunas) | 2022 | 35334544 | PubTator, text mining | PubMed |
| Clinicopathological Assessment of Cancer/Testis Antigens NY-ESO-1 and MAGE-A4 in Highly Aggressive Soft Tissue Sarcomas. | Diagnostics (Basel) | 2022 | 35328286 | PubTator, text mining | PubMed |
| Assessing the Future of Solid Tumor Immunotherapy. | Biomedicines | 2022 | 35327456 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4100/papers?page=14